Drug Type Protein drugs |
Synonyms- |
Target |
Mechanism CMYA5 inhibitors(cardiomyopathy associated 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Preclinical | CN | 07 Sep 2024 | |
Heart Failure | Preclinical | CN | 07 Sep 2024 | |
Heart Failure | Preclinical | CN | 07 Sep 2024 |